Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 13, 2015 - Issue 6
Submit an article Journal homepage
400
Views
10
CrossRef citations to date
0
Altmetric
Drug Profile

Darunavir/cobicistat once daily for the treatment of HIV

Thomas N KakudaJanssen Pharmaceutics, LLC, Titusville, NJ, USACorrespondence[email protected]
,
Herta CrauwelsJanssen Infectious Diseases BVBA, Beerse, Belgium
,
Magda OpsomerJanssen Infectious Diseases BVBA, Beerse, Belgium
,
Frank TomakaJanssen Pharmaceutics, LLC, Titusville, NJ, USA
,
Tom van de CasteeleJanssen Infectious Diseases BVBA, Beerse, Belgium
,
Simon VanveggelJanssen Infectious Diseases BVBA, Beerse, Belgium
,
Koen IterbekeJanssen Research and Development, Beerse, Belgium
&
Goedele de SmedtJanssen Infectious Diseases BVBA, Beerse, Belgium
 show all
Pages 691-704 | Published online: 11 May 2015

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shun Hayashi, Hiroko Kawaguchi, Takao Watanabe, Izuru Miyawaki, Tatsuki Fukami & Miki Nakajima. (2023) Estimation of contribution of CYP2D6 to tipepidine metabolism in humans and prolongation of the half-life of tipepidine by combination use with a CYP2D6 inhibitor in chimeric mice with humanised liver. Xenobiotica 53:4, pages 241-247.
Read now
Vagish Hemmige, Charlene A. Flash, Josephinel Carter, Thomas P. Giordano & Teddy Zerai. (2018) Single tablet HIV regimens facilitate virologic suppression and retention in care among treatment naïve patients. AIDS Care 30:8, pages 1017-1024.
Read now

Articles from other publishers (8)

Oliver Ackaert, David McDougall, Carlos Pérez-Ruixo, Juan Jose Pérez-Ruixo, John Jezorwski & Herta M. Crauwels. (2021) Population Pharmacokinetic Analysis of Darunavir and Tenofovir Alafenamide in HIV-1-Infected Patients on the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen (AMBER and EMERALD Studies). The AAPS Journal 23:4.
Crossref
Rongrong Wang, Limin Kong, Qiang Xu, Ping Yang, Xiaojuan Wang, Na Chen, Lu Li, Saiping Jiang & Xiaoyang Lu. (2021) On-ward participation of clinical pharmacists in a Chinese intensive care unit for patients with COVID-19: A retrospective, observational study. Research in Social and Administrative Pharmacy 17:1, pages 1853-1858.
Crossref
Ellen WeisbergMartin SattlerPriscilla L. YangAlexander ParentNathanael GrayJames D. Griffin. (2020) Current therapies under investigation for COVID-19: potential COVID-19 treatments. Canadian Journal of Physiology and Pharmacology 98:8, pages 483-489.
Crossref
Zhang-Ren Chen, Ying Zhou, Jin Liu, Hong-Wei Peng, Jian Zhou, Hai-Li Zhong, Li-Li Liu, Ming-Fang Lai, Xiao-Hua Wei & Jin-Hua Wen. (2020) Pharmacotherapics Advice in Guidelines for COVID-19. Frontiers in Pharmacology 11.
Crossref
HM Crauwels, O Osiyemi, C Zorrilla, C Bicer & K Brown. (2019) Reduced exposure to darunavir and cobicistat in HIV ‐1‐infected pregnant women receiving a darunavir/cobicistat‐based regimen . HIV Medicine 20:5, pages 337-343.
Crossref
Herta M. Crauwels, Bryan Baugh, Erika Landuyt, Simon Vanveggel, Anja Hijzen & Magda Opsomer. (2018) Bioequivalence of the Once‐Daily Single‐Tablet Regimen of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Compared to Combined Intake of the Separate Agents and the Effect of Food on Bioavailability. Clinical Pharmacology in Drug Development 8:4, pages 480-491.
Crossref
. (2016) International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK. Journal of the International AIDS Society 19, pages 21487.
Crossref
Alexandra Calmy & Delphine Sculier. (2015) Is monotherapy maintenance the way forward?. The Lancet HIV 2:10, pages e402-e403.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.